Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial

Secondary title: 
T2 - Anticancer research
Short title: 
Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial
Authors: 
Mystakidou, K.
Tsilika, E.
Kalaidopoulou, O.
Chondros, K.
Georgaki, S.
Papadimitriou, L.
Start page: 
1187-92
Annotations: 
Type B, Priority 5
Year: 
2002
Accession number: 
CN-00390740
Database: 
CENTRAL Issue 4 2014
Number: 
M1 - 2b
ID: 
958
Notes: 
N1 - Clinical Trial; Journal Article; Randomized Controlled Trial
Key words: 
Abdominal Neoplasms [complications]
Antiemetics [therapeutic use]
Butylscopolammonium Bromide [therapeutic use]
Chlorpromazine [therapeutic use]
Double-Blind Method
Gastrointestinal Agents [therapeutic use]
Gastrointestinal Neoplasms [complications]
Injections, Subcutaneous
Intestinal Obstruction [complications] [drug therapy] [etiology]
Nausea [drug therapy] [etiology]
Neoplasms [complications]
Octreotide [therapeutic use]
Palliative Care
Pelvic Neoplasms [complications]
Vomiting [drug therapy] [etiology]
Adult[checkword]
Aged[checkword]
Female[checkword]
Humans[checkword]
Male[checkword]
Middle Aged[checkword]
Sr-cancer: sr-uppergi
Types of evidence: 
Type B
Priorities of Care: 
Priority 5: Plan and do